MAPT and Alzheimer disease: Impaired insulin signaling, as the hallmark of diabetes mellitus, disrupts molecular pathways involving amyloid-β (Aβ) clearance and tau hyperphosphorylation, potentially contributing to synaptic dysfunction in AD.